Latest Updates

It's the first treatment for heart failure with preserved ejection fraction (HFpEF) in India

The gummies are formulated to cater to the specific needs of growing children

Once the deal is complete, Serum Institute Life Sciences will have about 15 per cent stake in Biocon Biologics, according to the…

Majority of the top 20 global biopharma companies reported a 2.1 per cent increase in aggregate MCAP, from $3.4 trillion on 31st…

The drug, called VV116, is a derivative of Gilead Sciences's COVID drug Remdesivir and was approved for use in moderate-to-severe…

The research, published in the journal 'Family Practice,' analysed the association between hormone replacement therapy or combined…

Brillo is a first-in-class drug which has a new mechanism of action compared to the currently available lipid-lowering agents

The company aims to establish collaboration for academic interaction and advancement of research in the specified fields, and to…

The deal gives AstraZeneca the rights to develop and sell six antibodies, none of which has been tested in humans so far

The appointment comes as Bert Labs continues to explore applications of Bert platform solution in several industry verticals and…